WOW! Coronavirus Vaccine Is Ready For Human Trial from April Claims Biotech Company
The good news is as per a recent report, a US biotech company’s first vaccine against coronavirus is now ready for a human trial.
The cases of the coronavirus are being reported from all over the world. Around 205 new cases are being reported from Iran. As per the National Health Commission, in China, the death toll due to the viral outbreak currently stands at 2,835, and infected people are more than 79,000.
A vaccine against the virus is one of the few hopes that we can have. Now the good news is as per a recent report, a US biotech company’s first vaccine against coronavirus is now ready for a human trial.
Moderna, a US Biotech Firm, has sent an experimental coronavirus vaccine to the US government researchers, in a time period as short as six weeks from the time they started working on the immunisation. The trials of this vaccine could start in April, but the whole process of testing & approvals could take at least a year.
Moderna in a press release statement said, that the first batch of the COVID-19 vaccine known as the mRNA-1273 has been sent to the National Institute of Allergy and Infectious Diseases. Adding to it, the company’s first trial would be conducted on a small number of healthy people, in the planned Phase 1 of the study for the vaccine. As per CNN report, around 45 people will participate in the first trial.
But, even if the first phase of testing is successful, then there will be further testing, regulatory approvals, etc. before the vaccine can be used for immunisation against the coronavirus.
Besides Moderna, other biotech companies are also looking out to find immunisation against the coronavirus. Some more global pharma giants, government scientists are also working on a vaccine. Though, in such a little time period in which researchers have made the vaccine ready for human trial is appreciable.
Scientists were ready with the vaccine within 42 days of receiving genetic information about the COVID-19, as compared to the vaccine for the SARS virus which took about 20 months to be ready for a human trial.